Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma-Reference-Cited by-同舟云学术

Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma

Published:2020-04-23 Issue:6 Volume:111 Page:1899-1909
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Deng Chuangzhong¹²^ORCID,Xu Yanyang¹²,Fu Jianchang²³,Zhu Xiaojun¹²,Chen Hongmin¹²,Xu Huaiyuan¹²,Wang Gaoyuan²,Song Yijiang¹²,Song Guohui¹²,Lu Jinchang¹²,Liu Ranyi²,Tang Qinglian¹²,Huang Wenlin²,Wang Jin¹²

Affiliation:

1. Department of Musculoskeletal Oncology Sun Yat‐sen University Cancer Center Guangzhou China

2. State Key Laboratory of Oncology in Southern China Collaborative Innovation Center of Cancer Medicine Guangzhou China

3. Department of Pathology Sun Yat‐sen University Cancer Center Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14398

Reference59 articles.

1. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

2. Osteosarcoma incidence and survival rates from 1973 to 2004

3. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution

4. Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

5. Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral Heterogeneity Assessment of the Extracellular Bone Matrix and Immune Microenvironment in Osteosarcoma Using Digital Imaging to Predict Therapeutic Response;Laboratory Investigation;2024-09

2. A cuproptosis-related lncRNAs signature predicts prognosis and reveals pivotal interactions between immune cells in colon cancer;Heliyon;2024-07

3. Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies;Frontiers in Cell and Developmental Biology;2024-06-10

4. From biology to personalized medicine: Recent knowledge in osteosarcoma;European Journal of Medical Genetics;2024-06

5. An injectable hydrogel microsphere-integrated training court to inspire tumor-infiltrating T lymphocyte potential;Biomaterials;2024-04